Journal profile · Biochemical Research Methods
Proteomics Clinical Applications
ISSN 1862-8346 · eISSN 1862-8354 · Wiley-VCH Verlag · GERMANY · Monthly · Founded 2007
Proteomics Clinical Applications: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 2.83; hybrid open access; APC about USD 4,430; median 182 days to acceptance (59 articles, last 24 months); community-reported acceptance: fairly easy; 52 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Proteomics Clinical Applications is published by Wiley-VCH Verlag and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications and Advanced Biosensing Techniques and Applications, together about 49% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
PROTEOMICS - Clinical Applications has developed into a key source of information in the field of applying proteomics and other omics methods to the study of human disease and translation to the clinic. With 6 issues per year, the journal publishes papers in all relevant areas including: basic (prote)omics research designed to further understand the molecular mechanisms underlying dysfunction in human disease the results of (prote)omics studies dedicated to the discovery and validation of diagnostic and prognostic disease biomarkers the use of (prote)omics for the discovery of novel drug targets the application of (prote)omics in the drug development pipeline the use of (prote)omics as a component of clinical trials. ISI Impact Factor 2020: 3.494 ISSN: 1862-8346 (print). 1862-8354 (online). Currently 12 issues per year.
From the journal's Aims & Scope
Research area (LetPub): Biochemical Research Methods
Editor-in-chief Garry Corthals FoundingPublisher website
Editorial board by country: 1 in mainland China (about 25%); most named Mainland China 1, Germany 1, Ireland 1, Thailand 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Proteomics Techniques and ApplicationsChemistry33.5%
- Mass Spectrometry Techniques and ApplicationsChemistry7.8%
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology7.7%
- Biotin and Related StudiesBiochemistry, Genetics and Molecular Biology6.9%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology4.8%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology4.2%
- Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology3.4%
- Monoclonal and Polyclonal Antibodies ResearchMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemical Research Methods | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.83LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- CiteScore (publisher) 2025
- 4.7Publisher website ·
- SJR 2026-06
- 0.73LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 43LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 1,023OpenAlex ·
- 2-year mean citedness
- 2.4OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 33.93%LetPub ·
Volume
- Articles per year
- 36LetPub ·
- Articles per year (publisher) 2025
- 37Publisher website ·
- Downloads per year (publisher) 2025
- 145,192Publisher website ·
Articles by year OpenAlex count · 2,363 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 14 | 7 |
| 2025 | 52 | 33 | 66 |
| 2024 | 67 | 42 | 266 |
| 2023 | 56 | 37 | 390 |
| 2022 | 60 | 23 | 432 |
| 2021 | 69 | 26 | 413 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
182 daysMedian, submission to acceptance · P25–P75 134 days – 253 days
- Acceptance to online
- median 17 days (59 articles)
- Submission to online
- median 203 days
- Sample
- 59 articles with submission and acceptance dates (81 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 23%Publisher website ·
- Acceptance rate (publisher) 2025
- 23%Publisher website ·
- Submission to first decision
- 17 daysPublisher website ·
- Submission to first decision 2025
- 17 daysPublisher website ·
- Submission to acceptance 2025
- 180 daysPublisher website ·
- Acceptance to publication 2025
- 19 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,430 / EUR 3,700 / GBP 3,010 | — | — | |
| Publisher website | No APC | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted9, with length limits
- editorialSeven types of scientific contributions are considered for publication: (i) Research Articles describing complete investigations. Unsolicited research articles …Length not stated
- rapid communicationSeven types of scientific contributions are considered for publication: (i) Research Articles describing complete investigations. Unsolicited research articles …Length not stated
- rapid communications(ii) Rapid Communications describing results that are brief, timely and/or of such importance that rapid publication is warranted.Length not stated
- research articleSeven types of scientific contributions are considered for publication: (i) Research Articles describing complete investigations. Unsolicited research articles …main text ≤ 8,000 words
- research articles(i) Research Articles describing complete investigations. Unsolicited research articles should be as concise as possible and should typically not exceed 8000 wo…Length not stated
- reviewSeven types of scientific contributions are considered for publication: (i) Research Articles describing complete investigations. Unsolicited research articles …main text ≤ 10,000 words
- review articleSeven types of scientific contributions are considered for publication: (i) Research Articles describing complete investigations. Unsolicited research articles …Length not stated
- reviews(iii) Reviews are normally invited by the Editor-in-Chief.Length not stated
- viewpointions in an italicized font can be used. Viewpoint articles should normally not exceed 3500 words (including references as well as figure and table legends)main text ≤ 3,500 words
Policy excerpts from the journal's websiteConflicts of interest, Data availability, Open access
- Conflicts of interest Conflict of Interest Statement
All authors must declare financial/commercial conflicts of interest. Even if there are none, this should be stated in a separate paragraph following on from the acknowledgements section. This is a mandatory requirement for all articles.
Source ↗Publisher website ·- Data availability 5.6 Data analysis, data sharing and accessibility
Including Data Availability Statement at the end of the paper is mandatory. Stating that data are available on a "reasonable request" is not acceptable. If data cannot be shared for a valid reason, conditions must be briefly outlined, for example if any agreements need to be signed etc. Data sharing is mandatory wherever possible, unless this is prevented by ethical or privacy concerns. Deposition…
Source ↗Publisher website ·- Open access
NIH mandate support Model summary
Wiley-Blackwell will support our authors by posting the accepted version of articles by NIH grant-holders to PubMed Central upon acceptance by the journal.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-VCH Verlag
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 2007
- ISSN
- 1862-8346
- Electronic ISSN
- 1862-8354
- Latest issue on the website
- Volume 20, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Proteomics Clinical Applications
What CAS zone is Proteomics Clinical Applications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Proteomics Clinical Applications is in Zone 3 of Biology, and in Zone 3 of the minor category Biochemical Research Methods. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Proteomics Clinical Applications?
The latest impact factor listed by LetPub is 2.83; CiteScore 4.7, h-index 76.
How long does peer review take at Proteomics Clinical Applications?
Based on the dates recorded on 59 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 182 days (interquartile range 134–253 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 23% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Proteomics Clinical Applications?
According to the journal's author guidelines: Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Proteomics Clinical Applications based?
Of the 4 board members whose country the journal's board page names, 1 (about 25%) are in mainland China; the countries named most often are Mainland China (1), Germany (1) and Ireland (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Proteomics Clinical Applications?
According to LetPub and DOAJ records, Proteomics Clinical Applications is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Proteomics Clinical Applications open access, and what is the APC?
Proteomics Clinical Applications is a hybrid journal. For open-access publication: APC about USD 4,430.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .